SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
1.240
0.00 (0.00%)
At close: May 16, 2025, 4:00 PM
1.280
+0.040 (3.23%)
After-hours: May 16, 2025, 5:39 PM EDT
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $293.00K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $428.00K. In the year 2024, SeaStar Medical Holding had annual revenue of $135.00K.
Revenue (ttm)
$428.00K
Revenue Growth
n/a
P/S Ratio
15.14
Revenue / Employee
$22,526
Employees
19
Market Cap
10.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 135.00K | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ICU News
- 1 day ago - SeaStar Medical Holding Corporation (ICU) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 days ago - SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury - GlobeNewsWire
- 9 days ago - SeaStar Medical to Report First Quarter Financial Results on May 14, 2025 - GlobeNewsWire
- 16 days ago - SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time - GlobeNewsWire
- 5 weeks ago - FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery - GlobeNewsWire
- 7 weeks ago - SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - GlobeNewsWire